Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-β-mediated Smad3 activation in fibroblasts

Tracy L. McGaha, Robert G. Phelps, Harry Spiera, Constantin Bona

Research output: Contribution to journalArticlepeer-review

169 Scopus citations

Fingerprint

Dive into the research topics of 'Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-β-mediated Smad3 activation in fibroblasts'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds